top of page
May 23, 2024
Clinical trials for patients with prostate cancer

Gary Ulaner, MD PhD, FACNM, PSNMMI

Dr. Gary Ulaner’s contributions positioned Hoag as a leader in molecular imaging and therapy development for prostate cancer. His endeavors are relevant to all men with prostate cancer and their families. Among these are:

• An imaging trial targeting prostate-specific antigen (PSA).  The FDA-approved imaging agent is poised to be the standard of care for pa-tients with prostate cancer. This trial not only detects tumors, but also treats them with radiation. 

• Evaluation of novel PET radiotracers for prostate cancer. These trials focused on imaging to guide precision therapy, using PET agents that target relevant receptors such as PSMA. His work demonstrated the value of PyL PET/CT (a PSMA-targeted imaging technique) for patients with prostate cancer. 


Clinical trials for patients with prostate cancer

Dr. Gary Ulaner is the James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California.

Gary has been the principal investigator of prospective clinical trials for eight novel PET radiotracers for patients with breast cancer, prostate cancer and myeloma, funded by two National Institutes of Health R01s, as well as grants from the Department of Defense (DoD) Breast Cancer Research Programs, Susan G. Komen Foundation, and Rising Tide Foundation. His clinical trials emphasize targeted imaging to guide targeted therapy of cancer, particularly ER, HER2, PSMA and CD38 targeted PET imaging.

Gary is on the editorial board of 4 leading radiology journals, authored the text “Fundamentals of Oncologic PET/CT”, and is on the scientific advisory boards of GE Healthcare, Lantheus, ImaginAb, Nuclidium, Precirix, and the Lobular Breast Cancer Alliance.

Gary currently lives in Irvine, California, with his wife, Alena, son, Ilya, and daughter, Anabel. He met his wife swing dancing, and they are still dancing today, albeit with less frequency.

Gary Ulaner, MD PhD, FACNM, PSNMMI

bottom of page